Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q6)Feb 28, 2025 | (FY)Aug 31, 2024 | (Q6)Feb 29, 2024 | (FY)Aug 31, 2023 | (Q6)Feb 28, 2023 | (FY)Aug 31, 2022 | (Q6)Feb 28, 2022 | (FY)Aug 31, 2021 | (Q6)Feb 28, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 146.67%898.31M | ---- | -68.02%364.17M | ---- | 1.09%1.14B | ---- | -34.09%1.13B | ---- | 1,072.63%1.71B | ---- |
| Profit adjustment | ||||||||||
| Impairment and provisions: | -96.57%6.9M | ---- | 2,895.71%201.07M | ---- | 116.38%6.71M | ---- | 30.61%3.1M | ---- | -66.98%2.38M | ---- |
| -Impairment of trade receivables (reversal) | -24.60%2.23M | ---- | -55.86%2.96M | ---- | 116.38%6.71M | ---- | 30.61%3.1M | ---- | -66.98%2.38M | ---- |
| -Impairment of goodwill | ---- | ---- | --180.71M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | -73.21%4.66M | ---- | --17.4M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | -32.81%37.34M | ---- | 235.67%55.57M | ---- | -155.77%-40.96M | ---- | 115.97%73.44M | ---- | -192.03%-459.81M | ---- |
| -Other fair value changes | -32.81%37.34M | ---- | 235.67%55.57M | ---- | -155.77%-40.96M | ---- | 115.97%73.44M | ---- | -192.03%-459.81M | ---- |
| Asset sale loss (gain): | -788.19%-52.79M | ---- | -142.86%-5.94M | ---- | 240.77%13.87M | ---- | -246.09%-9.85M | ---- | 131.00%6.74M | ---- |
| -Loss (gain) from sale of subsidiary company | ---56.98M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -62.27%4.19M | ---- | -34.73%11.11M | ---- | 269.73%17.02M | ---- | -35.76%4.6M | ---- | 241.31%7.16M | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | -441.58%-17.05M | ---- | 78.22%-3.15M | ---- | -3,333.02%-14.45M | ---- | -53.09%-421K | ---- |
| Depreciation and amortization: | 14.45%740.76M | ---- | 87.95%647.24M | ---- | 48.25%344.37M | ---- | 0.94%232.3M | ---- | 1.31%230.14M | ---- |
| -Amortization of intangible assets | 6.94%33.87M | ---- | 63.65%31.67M | ---- | 75.18%19.35M | ---- | -24.09%11.05M | ---- | -35.68%14.55M | ---- |
| Financial expense | -57.42%14.43M | ---- | 410.21%33.88M | ---- | -153.27%-10.92M | ---- | -60.45%20.51M | ---- | -30.00%51.84M | ---- |
| Special items | 7.10%16.72M | ---- | 111.15%15.61M | ---- | -543.65%-140.03M | ---- | 19.39%31.56M | ---- | -91.44%26.44M | ---- |
| Operating profit before the change of operating capital | 26.69%1.66B | ---- | -0.00%1.31B | ---- | -11.22%1.31B | ---- | -5.69%1.48B | ---- | 23.79%1.57B | ---- |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | -104.30%-4.57M | ---- | 199.41%106.35M | ---- | -490.49%-106.98M | ---- | 152.54%27.4M | ---- | -932.94%-52.14M | ---- |
| Accounts payable increase (decrease) | 556.24%92.12M | ---- | 47.13%-20.19M | ---- | -168.33%-38.19M | ---- | 333.24%55.89M | ---- | 63.82%-23.96M | ---- |
| Special items for working capital changes | -144.75%-127.9M | ---- | 138.33%285.81M | ---- | -215.68%-745.67M | ---- | 86.77%644.6M | ---- | 221.24%345.13M | ---- |
| Cash from business operations | -3.70%1.62B | -1.65%1.08B | 300.12%1.68B | 241.60%1.1B | -80.92%420.76M | -67.87%320.9M | 20.14%2.21B | -5.54%998.89M | 101.82%1.84B | 89.98%1.06B |
| Other taxs | ---- | ---- | 64.41%-2.43M | ---- | ---6.82M | ---- | ---- | ---- | ---- | ---- |
| Interest received - operating | -21.17%18.31M | -25.52%9.78M | -47.63%23.23M | -47.88%13.13M | 30.44%44.36M | 52.76%25.18M | 131.59%34.01M | --16.48M | 208.88%14.68M | ---- |
| Interest paid - operating | 38.08%-36.78M | 0.28%-24.35M | -50.61%-59.4M | -26.14%-24.42M | 29.58%-39.44M | 26.61%-19.36M | 3.95%-56M | -105.05%-26.38M | 43.00%-58.31M | 79.08%-12.86M |
| Special items of business | -34.36%29.19M | -35.11%4.6M | --44.47M | --7.09M | ---- | ---- | ---- | ---- | 18.31%208.15M | --83.35M |
| Net cash from operations | -3.40%1.63B | -2.19%1.07B | 303.34%1.69B | 234.22%1.09B | -80.81%418.87M | -66.96%326.72M | 9.16%2.18B | -12.32%988.99M | 102.46%2B | 127.82%1.13B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | ---- | ---- | ---- | -76.64%530K | 94.21%771K | 1.75%2.27M | -16.24%397K | -92.58%2.23M | -93.33%474K |
| Restricted cash (increase) decrease | -1,069.77%-1.51M | 8,412.50%681K | -101.17%-129K | -99.93%8K | -92.07%11.02M | 122.32%11.05M | 3,509.95%138.95M | ---49.48M | -97.20%3.85M | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --100M | ---- |
| Decrease in deposits (increase) | ---46.64M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | -6.59%2.92M | 26.72%294K | -82.29%3.13M | -99.10%232K | 2,680.94%17.66M | 3,961.13%25.91M | -40.65%635K | -30.50%638K | -53.48%1.07M | -41.49%918K |
| Purchase of fixed assets | 52.68%-857.08M | 65.87%-615.11M | 19.68%-1.81B | -185.96%-1.8B | -619.22%-2.26B | -324.07%-630.25M | -32.78%-313.57M | 1.44%-148.62M | 22.19%-236.15M | -19.84%-150.79M |
| Selling intangible assets | ---- | 700.00%8K | --24M | -99.69%1K | ---- | 2,073.33%326K | 168,388.89%15.16M | 114.29%15K | -79.55%9K | 133.33%7K |
| Purchase of intangible assets | 94.69%-5.11M | 90.95%-4.5M | 0.71%-96.34M | 15.76%-49.65M | 29.55%-97.03M | -1,540.52%-58.94M | -6,378.55%-137.73M | -93.38%-3.59M | 41.12%-2.13M | 41.18%-1.86M |
| Sale of subsidiaries | --47.52M | --76.9M | ---- | ---- | ---- | ---- | ---- | ---- | -75.32%533K | --533K |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 30.88%-134.71M | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | --603.15M | --200M | ---- | ---- | -74.57%101.81M | -87.23%51.13M |
| Cash on investment | ---- | ---- | ---- | 93.85%-36.9M | ---600M | -350.11%-600M | ---- | ---133.3M | 93.00%-50.67M | ---- |
| Other items in the investment business | -785.58%-12.66M | -2,701.47%-17.17M | ---1.43M | ---613K | ---- | ---- | ---- | ---- | -1,723.03%-633.81M | ---106.84M |
| Net cash from investment operations | 53.64%-872.56M | 70.42%-558.9M | 18.87%-1.88B | -79.73%-1.89B | -688.32%-2.32B | -214.77%-1.05B | 65.30%-294.29M | -61.77%-333.94M | -138.72%-847.97M | -425.66%-206.43M |
| Net cash before financing | 494.21%759.48M | 163.87%509.19M | 89.87%-192.66M | -10.05%-797.24M | -200.64%-1.9B | -210.59%-724.42M | 63.97%1.89B | -28.92%655.06M | 82.10%1.15B | 102.16%921.52M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -64.81%411M | -62.50%150M | 13.74%1.17B | --400M | 391.34%1.03B | ---- | -52.50%209M | -97.95%9M | -59.63%440M | 18.95%440M |
| Refund | 11.44%-1.1B | -68.89%-1.03B | -489.87%-1.24B | -279.08%-606.9M | 49.85%-210.2M | -0.01%-160.1M | 30.38%-419.15M | 73.41%-160.08M | 62.73%-602.07M | 62.58%-601.96M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | --752.74M | --752.74M | ---- | ---- |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -39.35%-648.12M | -26.61%-277.33M |
| Issuance expenses and redemption of securities expenses | ---427.36M | ---427.36M | ---- | ---- | ---822.27M | ---822.27M | ---- | ---- | ---- | ---- |
| Other items of the financing business | 50.81%-787K | 26.08%-530K | ---1.6M | ---717K | ---- | ---- | 112.54%106.82M | 112.55%106.82M | -2,250.67%-851.6M | -24,472.75%-851.2M |
| Net cash from financing operations | -1,233.44%-1.12B | -511.16%-1.31B | -453.27%-83.91M | 78.32%-213.84M | -102.35%-15.17M | -240.10%-986.35M | 138.65%644.31M | 154.35%704.04M | -195.52%-1.67B | -30.53%-1.3B |
| Effect of rate | 84.13%-624K | 181.51%1.67M | -108.48%-3.93M | -210.81%-2.05M | -10.18%46.38M | 111.10%1.85M | 1,323.80%51.63M | 20.00%-16.67M | 77.84%-4.22M | -81.93%-20.84M |
| Net Cash | -29.95%-359.4M | 21.10%-797.7M | 85.57%-276.57M | 40.90%-1.01B | -175.64%-1.92B | -225.88%-1.71B | 591.81%2.53B | 463.48%1.36B | -851.80%-515.09M | 30.32%-373.91M |
| Begining period cash | -11.83%2.09B | -11.83%2.09B | -44.09%2.37B | -44.09%2.37B | 156.10%4.24B | 156.10%4.24B | -23.87%1.66B | -23.87%1.66B | 2.33%2.18B | 2.33%2.18B |
| Cash at the end | -17.22%1.73B | -4.67%1.29B | -11.83%2.09B | -46.37%1.36B | -44.09%2.37B | -15.56%2.53B | 156.10%4.24B | 68.40%3B | -23.87%1.66B | 12.86%1.78B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | PricewaterhouseCoopers | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.